KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

KORU Medical Systems, Inc.NASDAQ: KRMD

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 46.36M shares rose 0.8% year over year, in line with the +0.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.8% holds above the trailing-twelve-month pace of +0.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
46.36M+0.4% QoQ
Last fiscal yearDec 2025
46.19M+0.8% YoY
LTMMar 2026
46.25M+0.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.8%——
1 year+0.8%——
3-year CAGR+0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
46.19M USD
Year-over-year change
+0.8%
4-year CAGR
+1.0%

Weighted Avg Shares (Diluted) vs competitors

How KRMD compares with its peers on the latest reported figures

  • KRMD's LTM Mar 2026 weighted avg shares (diluted) of 46.25M shares is the 4th highest of the 10 companies compared; the peer median is 39.55M shares.
  • Its year-over-year change of +0.8% is the 7th highest of 10, against a peer median of +13.3%.
  • Over three fiscal years its annual growth of +0.9% compares with a peer median of +8.6%.
KRMD Competitors Peer median
Weighted Avg Shares (Diluted) for KRMD and competitors
Company Period LTM YoY 3-year CAGR
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
OSUROraSure Technologies, Inc.LTM Mar 202672.2M -3.1%+0.4%
STIMNeuronetics, Inc.LTM Mar 202667.96M +71.5%+34.8%
KRMDKORU Medical Systems, Inc.LTM Mar 202646.25M +0.8%+0.9%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.78M +66.1%+8.6%
NYXHNyxoah S.A.LTM Mar 202639.55M +13.3%+13.9%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
INFUInfuSystem Holdings, Inc.LTM Mar 202621.05M -2.3%-0.7%
PREPrenetics Global LimitedLTM Mar 202615.04M +18.8%+40.5%
UTMDUtah Medical Products, Inc.LTM Mar 20263.21M -6.4%-3.8%
Peer median (excluding KRMD) 39.55M+13.3%+8.6%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.